Intellipharmaceutics International Inc. filed its Annual on Feb 28, 2022 for the period ending Nov 30, 2021. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% |
|
-11.11% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 1.94M | |
+62.55% | 841B | |
+40.14% | 625B | |
-4.31% | 360B | |
+18.78% | 327B | |
+10.41% | 300B | |
+15.85% | 242B | |
+18.49% | 227B | |
+13.90% | 174B | |
+0.92% | 162B |
- Stock Market
- Equities
- IPCI.H Stock
- News Intellipharmaceutics International Inc.
- Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt